Patients with acromegaly might not be at higher risk for dopamine agonist-induced impulse control disorders than those with prolactinomas

To evaluate the prevalence of impulse control disorders (ICD) and psychiatric symptoms in patients with acromegaly receiving dopamine agonists (DA) in comparison with those with prolactinoma, nonfunctioning pituitary adenomas (NFA), and healthy controls (HC). Forty patients with acromegaly, 40 with...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Growth hormone & IGF research 2020-12, Vol.55, p.101356-101356, Article 101356
Hauptverfasser:	Ozkaya, Hande Mefkure, Sahin, Serdar, Korkmaz, Ozge Polat, Durcan, Emre, Sahin, Humeyra Rekali, Celik, Emir, Poyraz, Burc Cagri, Kadioglu, Pinar
Format:	Artikel
Sprache:	eng
Schlagworte:	Acromegaly Dopamine agonist Impulse control disorder Prevalence
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!